Evommune, Inc. Common Stock (EVMN)
R&D Expense Growth
15.25%
Fiscal year · Period ending:
EVMN R&D Expense Growth
Latest reported15.25%period ending
Latest reported15.25%period ending
EVMN FY R&D Growth (YoY) (0.00% → 15.25%)
Latest values, visible window
High-resolution chart · PNG
EVMN r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 15.2512% | |
| 100.7813% | |
| 0% |